Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice.

Jain A, Olsen HS, Vyzasatya R, Burch E, Sakoda Y, Mérigeon EY, Cai L, Lu C, Tan M, Tamada K, Schulze D, Block DS, Strome SE.

Arthritis Res Ther. 2012 Aug 20;14(4):R192. doi: 10.1186/ar4024.

2.

Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis.

Thiruppathi M, Sheng JR, Li L, Prabhakar BS, Meriggioli MN.

J Autoimmun. 2014 Aug;52:64-73. doi: 10.1016/j.jaut.2013.12.014. Epub 2014 Jan 2.

3.

Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.

Tremblay T, Paré I, Bazin R.

Transfusion. 2013 Feb;53(2):261-9. doi: 10.1111/j.1537-2995.2012.03725.x. Epub 2012 Jun 7.

PMID:
22670706
4.

Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia.

Teeling JL, Jansen-Hendriks T, Kuijpers TW, de Haas M, van de Winkel JG, Hack CE, Bleeker WK.

Blood. 2001 Aug 15;98(4):1095-9.

5.
6.

The antiinflammatory IgG.

Kaveri SV, Lacroix-Desmazes S, Bayry J.

N Engl J Med. 2008 Jul 17;359(3):307-9. doi: 10.1056/NEJMcibr0803649. No abstract available.

PMID:
18635437
7.

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV.

Science. 2008 Apr 18;320(5874):373-6. doi: 10.1126/science.1154315.

8.

Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.

Song S, Crow AR, Freedman J, Lazarus AH.

Blood. 2003 May 1;101(9):3708-13. Epub 2002 Dec 27.

9.

Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.

Leontyev D, Katsman Y, Ma XZ, Miescher S, Käsermann F, Branch DR.

Transfusion. 2012 Aug;52(8):1799-805. doi: 10.1111/j.1537-2995.2011.03517.x. Epub 2012 Jan 18.

PMID:
22257295
10.

Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.

Siragam V, Crow AR, Brinc D, Song S, Freedman J, Lazarus AH.

Nat Med. 2006 Jun;12(6):688-92. Epub 2006 May 21.

PMID:
16715090
11.

Effect of immunoglobulin G (IgG) interchain disulfide bond cleavage on efficacy of intravenous immunoglobulin for immune thrombocytopenic purpura (ITP).

Machino Y, Ohta H, Suzuki E, Higurashi S, Tezuka T, Nagashima H, Kohroki J, Masuho Y.

Clin Exp Immunol. 2010 Dec;162(3):415-24. doi: 10.1111/j.1365-2249.2010.04255.x. Epub 2010 Oct 5.

12.
13.

Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb.

Magnusson SE, Andrén M, Nilsson KE, Sondermann P, Jacob U, Kleinau S.

Clin Immunol. 2008 May;127(2):225-33. doi: 10.1016/j.clim.2008.02.002. Epub 2008 Mar 17.

PMID:
18346938
14.

Chemically dimerized intravenous immunoglobulin has potent ameliorating activity in a mouse immune thrombocytopenic purpura model.

Machino Y, Suzuki E, Higurashi S, Ohta H, Suzuki M, Kohroki J, Masuho Y.

Biochem Biophys Res Commun. 2012 Feb 24;418(4):748-53. doi: 10.1016/j.bbrc.2012.01.092. Epub 2012 Jan 28.

PMID:
22306012
15.

Monovalent Fc receptor blockade by an anti-Fcγ receptor/albumin fusion protein ameliorates murine ITP with abrogated toxicity.

Yu X, Menard M, Prechl J, Bhakta V, Sheffield WP, Lazarus AH.

Blood. 2016 Jan 7;127(1):132-8. doi: 10.1182/blood-2015-08-664656. Epub 2015 Oct 23.

16.

Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).

Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.

Ann Rheum Dis. 2008 Feb;67(2):154-61. Epub 2007 Jun 8.

PMID:
17557887
17.
18.

Comparative efficacy of TACI-Ig with TNF-alpha inhibitor and methotrexate in DBA/1 mice with collagen-induced arthritis.

Zhang L, Li P, Song S, Liu Y, Wang Q, Chang Y, Wu Y, Chen J, Zhao W, Zhang Y, Zhou A, Wei W.

Eur J Pharmacol. 2013 May 15;708(1-3):113-23. doi: 10.1016/j.ejphar.2013.02.025. Epub 2013 Feb 27.

PMID:
23454555
19.

Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.

Song S, Crow AR, Siragam V, Freedman J, Lazarus AH.

Blood. 2005 Feb 15;105(4):1546-8. Epub 2004 Oct 12.

20.

Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice.

Huang HS, Sun DS, Lien TS, Chang HH.

Blood. 2010 Dec 2;116(23):5002-9. doi: 10.1182/blood-2010-03-275123. Epub 2010 Aug 10.

Supplemental Content

Support Center